Your browser doesn't support javascript.
loading
Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis.
Pato-Cour, Esperanza; Martin-Martinez, Mª Auxiliadora; Borrego-Sanz, Lara; Martinez-Costa, Lucia; Esteban-Ortega, Mar; Sánchez-Costa, Jesús T; Cordero-Coma, Miguel; Fonollosa, Alejandro; Diaz-Valle, Teresa; Rodríguez-González, Fayna; Sainz-de-la-Maza, Maite; Diaz-Valle, David; Gonzalez-Ocampo, Samuel; López-Sierra, Sara; Garcia-Lozano, Isabel; Garzo-García, Irene; Artaraz, Joseba; Gurrea-Almela, Maria; Tejera, Marta; Moll-Udina, Aina; Valls-Pascual, Elia; Muñoz-Fernández, Santiago; Méndez-Fernandez, Rosalía.
Afiliação
  • Pato-Cour E; Rheumatology Department and Health Research Institute (IdISSC), Hospital Clínico San Carlos, C/ Profesor Martin Lagos s/n, 28040, Madrid, Spain. esperanza.pato@salud.madrid.org.
  • Martin-Martinez MA; Research Unit of Spanish Society of Rheumatology, Madrid, Spain.
  • Borrego-Sanz L; Ophthalmology Department and Health Research Institute (IdISSC), Hospital Clínico San Carlos, Cooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality, Instituto de Salud Carlos III, Madrid, Spain.
  • Martinez-Costa L; Ophthalmology Department, Hospital Universitario Doctor Peset, Valencia, Spain.
  • Esteban-Ortega M; Ophthalmology Department, Hospital Universitario Infanta Sofia, San Sebastian de los Reyes, Madrid, Spain.
  • Sánchez-Costa JT; Research Unit of Spanish Society of Rheumatology, Madrid, Spain.
  • Cordero-Coma M; Ophthalmology Department, Hospital Universitario de León, León, Spain.
  • Fonollosa A; Ophthalmology Department, BioCruces Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain.
  • Diaz-Valle T; Ophthalmology Department, Hospital Universitario de Móstoles, Móstoles, Madrid, Spain.
  • Rodríguez-González F; Ophthalmology Department, Hospital de Gran Canaria Doctor Negrín, Gran Canaria, Spain.
  • Sainz-de-la-Maza M; Ophthalmology Department, Hospital Clínic of Barcelona, Barcelona, Spain.
  • Diaz-Valle D; Ophthalmology Department and Health Research Institute (IdISSC), Hospital Clínico San Carlos, Cooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality, Instituto de Salud Carlos III, Madrid, Spain.
  • Gonzalez-Ocampo S; Ophthalmology Department, Hospital Universitario Doctor Peset, Valencia, Spain.
  • López-Sierra S; Ophthalmology Department, Hospital Universitario Doctor Peset, Valencia, Spain.
  • Garcia-Lozano I; Ophthalmology Department, Hospital Universitario Infanta Sofia, San Sebastian de los Reyes, Madrid, Spain.
  • Garzo-García I; Ophthalmology Department, Hospital Universitario de León, León, Spain.
  • Artaraz J; Ophthalmology Department, BioCruces Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain.
  • Gurrea-Almela M; Ophthalmology Department, Hospital Universitario de Móstoles, Móstoles, Madrid, Spain.
  • Tejera M; Ophthalmology Department, Hospital de Gran Canaria Doctor Negrín, Gran Canaria, Spain.
  • Moll-Udina A; Ophthalmology Department, Hospital Clínic of Barcelona, Barcelona, Spain.
  • Valls-Pascual E; Rheumatology Department, Hospital Universitario Doctor Peset, Valencia, Spain.
  • Muñoz-Fernández S; Rheumatology Department, Hospital Universitario Infanta Sofia, San Sebastian de los Reyes, Madrid, Spain.
  • Méndez-Fernandez R; Ophthalmology Department and Health Research Institute (IdISSC), Hospital Clínico San Carlos, Cooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality, Instituto de Salud Carlos III, Madrid, Spain.
Ophthalmol Ther ; 12(2): 1045-1055, 2023 Apr.
Article em En | MEDLINE | ID: mdl-36683123
ABSTRACT

INTRODUCTION:

Uveitis is the inflammation of the middle layer of the eye, the uvea, and is a major cause of blindness. None of the instruments used in clinical practice are, in themselves, sufficient to evaluate the course of uveitis. Therefore, it is necessary to develop instruments enabling standardized measurement of inflammatory activity. We developed a composite disease activity index for patients with uveitis known as UVEDAI, which considers the overall activity of the eye. The objective of this study was to validate the composite index of ocular inflammation, UVEDAI.

METHODS:

A multicenter cross-sectional study involving eight Spanish tertiary hospitals. Sixty-two patients aged ≥ 18 years with acute uveitis were recruited. Participants gave informed consent before participating in the study. A full ophthalmological examination was performed by two ophthalmologists to determine inflammatory activity one used the UVEDAI score and the other used clinical judgment. The ophthalmologists did not share their findings with each other to avoid introducing bias into the analysis. Construct validity was established by means of factor analysis. The criterion validity of the index was determined using an ordinal multivariate regression model, in which the dependent variable was the degree of uveal inflammation (mild, moderate, or high/severe). Cut-off points were determined for the UVEDAI and for the receiver operating characteristic (ROC) curves.

RESULTS:

Sixty-two patients were included. Total variance with the three components accounted for 80.32% of the construct validity. Each of the three components identified one type of eye involvement. The discriminatory capacity of UVEDAI was 0.867 (95% CI 0.778; 0.955 p < 0.001) for mild versus moderate-high and 0.946 (95% CI 0.879; 1.000 p < 0.001) for high versus mild-moderate.

CONCLUSIONS:

The variables included in UVEDAI enable ocular inflammatory activity to be described with a high degree of accuracy. The index may be used to evaluate and classify this activity with considerable discriminatory power.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Revista: Ophthalmol Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Revista: Ophthalmol Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha